Total body irradiation (TBI) has been used as a form of systemic therapy for the treatment of hematological malignancies and as a pre-conditioning regimen prior to bone marrow transplant. However, standard techniques are associated with both acute and chronic toxicities due to the large volumes of normal tissue irradiated. Intensity modulated radiation therapy (IMRT), with its ability to conform the high dose region to the shape of the target, offers a method to reduce radiation related sequelae and potentially allow for the delivery of higher than conventional doses. The goal of this study is to investigate the feasibility of a linac-based approach to intensity modulated total marrow irradiation (IM-TMI) and to discuss the challenges associated with its clinical implementation. The successful development of linac-based IM-TMI would represent advancement in the field of radiotherapy and potentially reduce the incidence and severity of complications associated with current TBI techniques.
GilsonD.TaylorR. E.Total Body Irradiation. Report on a Meeting Organized by the BIR Oncology Committee, Held at The Royal Institute of British Architects, London, 28 November 1996. Br. J. Radiol.70, 1201–1203 (1997).
2.
LinH. S.DrzymalaR. E.Magna-field Irradiation. In Principles and Practice of Radiation Oncology. Eds., PerezC. A.BradyL. W.HalperinC. E.Lippincott Williams and Wilkins (2003).
3.
GirinskyT.SocieG.AmmarguellatH.Consequences of Two Different Doses to the Lungs During a Single Dose of Total Body Irradiation: Results of a Randomized Study on 85 Patients. Int. J. Radiat. Oncol. Biol. Phys.30, 821–824 (1994).
4.
TravisL. B.WeeksJ.CurtisR. E.Leukemia Following Low-dose Total Body Irradiation and Chemotherapy for Non-Hodgkin's Lymphoma. J. Clin. Oncol.14, 565–571 (1996).
5.
PollackA.ZagarsG. K.RosenI. I.Prostate Cancer Treatment with Radiotherapy: Maturing Methods that Minimize Morbidity. Semin. Oncol.26, 150–161 (1999).
6.
MundtA. J.LujanA. E.RotmenschJ.Intensity-modulated Whole Pelvic Radiotherapy in Women with Gynecologic Malignancies. Int. J. Radiat. Oncol. Biol. Phys.52, 1330–1337 (2002).
7.
ChaoK. S.MajhailN.HuangC. J.Intensity-modulated Radiation Therapy Reduces Late Salivary Toxicity Without Compromising Tumor Control in Patients with Oropharyngeal Carcinoma: A Comparison with Conventional Techniques. Radiother. Oncol.61, 275–280 (2001).
8.
WuQ.ManningM.Schmidt-UllrichR.The Potential for Sparing of Parotids and Escalation of Biologically Effective Dose with Intensity-modulated Radiation Treatments of Head and Neck Cancers: A Treatment Design Study. Int. J. Radiat. Oncol. Biol. Phys.46, 195–205 (2000).
9.
MehtaM.ScrimgerR.MackieR.A New Approach to Dose Escalation in Non-small-cell Lung Cancer. Int. J. Radiat. Oncol. Biol. Phys.49, 23–33 (2001).
10.
StieberV. W.MunleyT. M.Central Nervous System Tumors. In Intensity Modulated Radiation Therapy, A Clinical Perspective, pp. 231–241. Eds., MundtA. J.RoeskeJ. C. Hamilton, Ontario: BC Decke Inc. (2005).
11.
WongJ. Y.LiuA.SchultheissT.Targeted Total Marrow Irradiation Using Three-dimensional Image-guided Tomographic Intensity-modulated Radiation Therapy: An Alternative to Standard Total Body Irradiation. Biol. Blood Marrow Transplant12, 306–315 (2006).
12.
HuiS. K.KapatoesJ.FowlerJ.Feasibility Study of Helical Tomotherapy for Total Body or Total Marrow Irradiation. Med. Phys.32, 3214–3224 (2005).
13.
RoeskeJ. C.LujanA.RotmenschJ.Intensity-modulated Whole Pelvic Radiation Therapy in Patients with Gynecologic Malignancies. Int. J. Radiat. Oncol. Biol. Phys.48, 1613–1621 (2000).
14.
WuQ.ArnfieldM.TongS.Dynamic Splitting of Large Intensity-modulated Fields. Phys. Med. Biol.45, 1731–1740 (2000).
15.
HongL.AlektiarK.ChuiC.IMRT of Large Fields: Whole-Abdomen Irradiation. Int. J. Radiat. Oncol. Biol. Phys.54, 278–289 (2002).
16.
ZygmanskiP.HackerF.FriesenS.Maximum MLC Opening Effect in Dynamic Delivery of IMRT: Leaf-positional Analysis. J Appl. Clin. Med. Phys.6, 33–43 (2005).
17.
HaiounC.LepageE.GisselbrechtC.Benefit of Autologous Bone Marrow Transplantation Over Sequential Chemotherapy in Poor-risk Aggressive Non-Hodgkin's Lymphoma: Updated Results of the Prospective Study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J. Clin. Oncol.15, 1131–1137 (1997).
18.
MinkS. A.ArmitageJ. O.High-dose Therapy in Lymphomas: A Review of the Current Status of Allogeneic and Autologous Stem Cell Transplantation in Hodgkin's Disease and Non-Hodgkin's Lymphoma. Oncologist6, 247–256 (2001).
19.
AndersonJ. E.AppelbaumF. R.SchochG.Allogeneic Marrow Transplantation for Refractory Anemia: A Comparison of Two Preparative Regimens and Analysis of Prognostic Factors. Blood87, 51–58 (1996).
20.
CliftR. A.BucknerC. D.AppelbaumF. R.Allogeneic Marrow Transplantation in Patients with Acute Myeloid Leukemia in First Remission: A Randomized Trial of Two Irradiation Regimens. Blood76, 1867–1871 (1990).
21.
PetersenF. B.DeegH. J.BucknerC. D.Marrow Transplantation Following Escalating Doses of Fractionated Total Body Irradiation and Cyclophosphamide — A Phase I Trial. Int. J. Radiat. Oncol. Biol. Phys.23, 1027–1032 (1992).
22.
DatzF. L. and TaylorA.The Cinical Use of Radionuclide Bone Marrow Imaging. Semin. Nucl. Med.15, 239–259 (1985).
23.
RoeskeJ. C.LujanA.RebaR. C.Incorporation of SPECT Bone Marrow Imaging into Intensity Modulated Whole-pelvic Radiation Therapy Treatment Planning for Gynecologic Malignancies. Radiotherapy and Oncology77, 11–17 (2005).
